Effects of intermittent T-cell cluster disaggregation on proliferative capacity and checkpoint marker expression
Background/aim: T-cell immunotherapies are rapidly gaining grounds in clinical success. Presently, there is first-to-market knowledge on the translation of research scale methods to clinical and commercial scales. Improved understanding can lead to more consistent and efficient production, scaling,...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2019-04-01
|
| Col·lecció: | Autoimmunity |
| Matèries: | |
| Accés en línia: | http://dx.doi.org/10.1080/08916934.2019.1630064 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|